Statement of Ownership (sc 13g)
April 13 2017 - 6:06AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
13G
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
Lixte
Biotechnology Holdings, Inc.
(Name
of Issuer)
Common
Stock, $0.0001 par value per share
(Title
of Class of Securities)
539319
10 3
(CUSIP
Number)
February
24, 2017
(Date
of Event Which Requires Filing of this Statement)
Check
the appropriate box to designate the rule pursuant to which this Schedule is filed:
|
|
[ ]
|
Rule 13d-1(b)
|
|
|
|
|
|
|
[X]
|
Rule 13d-1(c)
|
|
|
|
|
|
|
[ ]
|
Rule 13d-1(d)
|
*The
remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided
in a prior cover page.
The
information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section
18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act
but shall not be subject to all other provisions of the Act (however, see the Notes).
|
CUSIP NO. 539319 10 3
|
Page
2
of
6 Pages
|
|
|
1.
|
NAMES
OF REPORTING PERSONS.
Lalit
Bahl
|
|
|
|
|
|
|
|
|
2.
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
[ ]
(b)
[X]
|
|
|
|
|
|
|
|
|
|
3.
|
SEC
USE ONLY
|
|
|
|
|
|
|
|
|
4.
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States
|
|
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
|
|
|
5.
|
SOLE
VOTING POWER
|
0
|
|
|
|
6.
|
SHARED
VOTING POWER
|
4,000,000
|
|
|
|
7.
|
SOLE
DISPOSITIVE POWER
|
0
|
|
|
|
8.
|
SHARED
DISPOSITIVE POWER
|
4,000,000
|
|
|
|
|
|
|
9.
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON.
4,000,000
|
|
|
|
|
|
|
|
|
10.
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN
SHARES
[ ]
|
|
|
|
|
11.
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
[1]
8.35%
|
|
|
|
|
12.
|
TYPE
OF REPORTING PERSON
IN
|
|
|
|
|
|
|
|
|
|
|
1
Based
on 47,875,814 shares of common stock outstanding as of November 1, 2016, as reflected in the Issuer’s Form 10-Q for
the quarter ended September 30, 2016.
|
CUSIP NO. 539319 10 3
|
Page
3
of
6 Pages
|
|
|
|
|
1.
|
NAMES
OF REPORTING PERSONS.
Kavita
K. Kinra
|
|
|
|
|
|
|
|
|
2.
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
[ ]
(b)
[X]
|
|
|
|
|
|
|
|
|
|
3.
|
SEC
USE ONLY
|
|
|
|
|
4.
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States
|
|
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
|
|
|
5.
|
SOLE
VOTING POWER
|
0
|
|
|
|
6.
|
SHARED
VOTING POWER
|
4,000,000
|
|
|
|
7.
|
SOLE
DISPOSITIVE POWER
|
0
|
|
|
|
8.
|
SHARED
DISPOSITIVE POWER
|
4,000,000
|
|
|
|
|
|
|
9.
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON.
4,000,000
|
|
|
|
|
|
|
|
|
10.
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN
SHARES
[ ]
|
|
|
|
|
11.
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
[2]
8.35%
|
|
|
|
|
12.
|
TYPE
OF REPORTING PERSON
IN
|
|
|
|
|
|
|
|
|
|
|
1
Based
on 47,875,814 shares of common stock outstanding as of November 1, 2016, as reflected in the Issuer’s Form 10-Q for
the quarter ended September 30, 2016.
|
CUSIP NO. 539319 10 3
|
Page
4
of
6 Pages
|
Item
1(a). Name of Issuer.
The
name of the issuer is Lixte Biotechnology Holdings, Inc. (the “Issuer”).
Item
1(b). Address of Issuer’s Principal Executive Offices.
The
address of the Issuer’s principal executive office is 248 Route 25A, No. 2, East Setauket, New York 11733.
Item
2(a). Name of Person Filing.
The
names of the individuals are Lalit Bahl and Kavita K. Kinra (each a “Reporting Person”).
Item
2(b). Address of Principal Business Office, or, if None, Residence.
The
address of Reporting Persons is c/o the Company, 248 Route 25A, No. 1, East Setauket, New York 11733.
Item
2(c). Citizenship.
Each
of the Reporting Persons is a United States citizen.
Item
2(d). Title of Class of Securities.
The
title of the class of securities to which this statement relates is the common stock of the Issuer, $0.0001 par value per share
(the “Common Stock”).
Item
2(e). CUSIP No.
The
CUSIP number is 539319103.
Item
3. If This Statement is Filed Pursuant to Rule 13d-1(b) or 13d-2(b), Check Whether the Person Filing is a:
|
(a)
|
[ ]
|
Broker
or dealer registered under Section 15 of the Act
|
|
|
|
|
|
(b)
|
[ ]
|
Bank
as defined in Section 3(a)(6) of the Act
|
|
|
|
|
|
(c)
|
[ ]
|
Insurance
Company as defined in Section 3(a)(19) of the Act
|
|
|
|
|
|
(d)
|
[ ]
|
Investment
Company registered under Section 8 of the Investment Company Act of 1940
|
|
|
|
|
|
(e)
|
[ ]
|
Investment
Adviser registered under section 203 of the Investment Advisers Act of 1940
|
|
|
|
|
|
(f)
|
[ ]
|
Employee
Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment
Fund; see Rule 13d-1(b)(1)(ii)(F)
|
|
|
|
|
|
(g)
|
[ ]
|
Parent
Holding Company, in accordance with Rule 13d-1(b)(1)(ii)(G) (Note: See Item 7)
|
|
|
|
|
|
(h)
|
[ ]
|
Group,
in accordance with Rule 13d-1(b)(1)(ii)(H).
|
Item
4. Ownership.
The
information required by Items 4(a) – (c) is set forth in Rows 5 – 11 of the cover pages and is incorporated herein
by reference. The Reporting Persons hold the securities as JTWROS.
|
CUSIP NO. 539319 10 3
|
Page
5
of
6 Pages
|
Item
5. Ownership of Five Percent or Less of a Class.
If
this Schedule is being filed to report the fact that as of the date hereof the Reporting Person has ceased to be the beneficial
owner of more than five percent of the class of securities, check the following [ ].
Item
6. Ownership of More than Five Percent on Behalf of Another Person.
Not
Applicable.
Item
7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
Not
Applicable.
Item
8. Identification and Classification of Members of the Group.
Not
Applicable.
Item
9. Notice of Dissolution of Group.
Not
Applicable.
Item
10. Certifications.
By
signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were
not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
|
CUSIP NO. 539319 10 3
|
Page
6
of
6 Pages
|
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
|
|
Dated:
April 12, 2017
|
|
|
|
|
|
/s/
LALIT BAHL
|
|
|
Lalit Bahl
|
|
|
/s/
KAVITA K. KINRA
|
|
|
Kavita K.
Kinra
|